These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 20496889)
1. Development of [F-18]fluorine-substituted Tanaproget as a progesterone receptor imaging agent for positron emission tomography. Lee JH; Zhou HB; Dence CS; Carlson KE; Welch MJ; Katzenellenbogen JA Bioconjug Chem; 2010 Jun; 21(6):1096-104. PubMed ID: 20496889 [TBL] [Abstract][Full Text] [Related]
2. Imaging progesterone receptor in breast tumors: synthesis and receptor binding affinity of fluoroalkyl-substituted analogues of tanaproget. Zhou HB; Lee JH; Mayne CG; Carlson KE; Katzenellenbogen JA J Med Chem; 2010 Apr; 53(8):3349-60. PubMed ID: 20355713 [TBL] [Abstract][Full Text] [Related]
3. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization. Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228 [TBL] [Abstract][Full Text] [Related]
4. First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography. Schottelius M; Poethko T; Herz M; Reubi JC; Kessler H; Schwaiger M; Wester HJ Clin Cancer Res; 2004 Jun; 10(11):3593-606. PubMed ID: 15173065 [TBL] [Abstract][Full Text] [Related]
5. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters. Goswami R; Ponde DE; Kung MP; Hou C; Kilbourn MR; Kung HF Nucl Med Biol; 2006 Aug; 33(6):685-94. PubMed ID: 16934687 [TBL] [Abstract][Full Text] [Related]
6. Gao F; Peng C; Zhuang R; Guo Z; Liu H; Huang L; Li H; Xu D; Wen X; Fang J; Zhang X Nucl Med Biol; 2019; 72-73():62-69. PubMed ID: 31330414 [TBL] [Abstract][Full Text] [Related]
7. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative. Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of [11C]hemicholinium-15 and [18F]hemicholinium-15 as new potential PET tracers for the high-affinity choline uptake system in the heart. Gao M; Miller MA; DeGrado TR; Mock BH; Lopshire JC; Rosenberger JG; Dusa C; Das MK; Groh WJ; Zipes DP; Hutchins GD; Zheng QH Bioorg Med Chem; 2007 Feb; 15(3):1289-97. PubMed ID: 17116396 [TBL] [Abstract][Full Text] [Related]
9. Fluorinated androgens and progestins: molecular probes for androgen and progesterone receptors with potential use in positron emission tomography. Brandes SJ; Katzenellenbogen JA Mol Pharmacol; 1987 Sep; 32(3):391-403. PubMed ID: 3499564 [TBL] [Abstract][Full Text] [Related]
10. Fluorine-18-labeled progestin 16 alpha, 17 alpha-dioxolanes: development of high-affinity ligands for the progesterone receptor with high in vivo target site selectivity. Buckman BO; Bonasera TA; Kirschbaum KS; Welch MJ; Katzenellenbogen JA J Med Chem; 1995 Jan; 38(2):328-37. PubMed ID: 7830275 [TBL] [Abstract][Full Text] [Related]
11. 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone: synthesis and target tissue selective uptake of a progestin receptor based radiotracer for positron emission tomography. Pomper MG; Katzenellenbogen JA; Welch MJ; Brodack JW; Mathias CJ J Med Chem; 1988 Jul; 31(7):1360-3. PubMed ID: 3260285 [TBL] [Abstract][Full Text] [Related]
12. A fluorine-18 labeled progestin as an imaging agent for progestin receptor positive tumors with positron emission tomography. Verhagen A; Elsinga PH; de Groot TJ; Paans AM; de Goeij CJ; Sluyser M; Vaalburg W Cancer Res; 1991 Apr; 51(7):1930-3. PubMed ID: 2004378 [TBL] [Abstract][Full Text] [Related]
13. Fluorine-18-labeled progestin ketals: synthesis and target tissue uptake selectivity of potential imaging agents for receptor-positive breast tumors. Kochanny MJ; VanBrocklin HF; Kym PR; Carlson KE; O'Neil JP; Bonasera TA; Welch MJ; Katzenellenbogen JA J Med Chem; 1993 Apr; 36(9):1120-7. PubMed ID: 8487253 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of 7α-(3-[(18)F]fluoropropyl) estradiol. Okamoto M; Naka K; Kitagawa Y; Ishiwata K; Yoshimoto M; Shimizu I; Toyohara J Nucl Med Biol; 2015 Jul; 42(7):590-7. PubMed ID: 25823392 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of 2'-deoxy-2'-18F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression. Alauddin MM; Shahinian A; Park R; Tohme M; Fissekis JD; Conti PS J Nucl Med; 2004 Dec; 45(12):2063-9. PubMed ID: 15585483 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and preliminary evaluation of a Wu X; You L; Zhang D; Gao M; Li Z; Xu D; Zhang P; Huang L; Zhuang R; Wu H; Zhang X Chem Biol Drug Des; 2017 Apr; 89(4):559-565. PubMed ID: 27696769 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of an estrogen receptor beta-selective radioligand: 5-[18F]fluoro-(2R,3S)-2,3-bis(4-hydroxyphenyl)pentanenitrile and comparison of in vivo distribution with 16alpha-[18F]fluoro-17beta-estradiol. Yoo J; Dence CS; Sharp TL; Katzenellenbogen JA; Welch MJ J Med Chem; 2005 Oct; 48(20):6366-78. PubMed ID: 16190762 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of N₄'-[¹⁸F]fluoroalkylated ciprofloxacin as a potential bacterial infection imaging agent for PET study. Sachin K; Kim EM; Cheong SJ; Jeong HJ; Lim ST; Sohn MH; Kim DW Bioconjug Chem; 2010 Dec; 21(12):2282-8. PubMed ID: 21049983 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of a bromine-76-labeled progestin 16alpha,17alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies. Zhou D; Sharp TL; Fettig NM; Lee H; Lewis JS; Katzenellenbogen JA; Welch MJ Nucl Med Biol; 2008 Aug; 35(6):655-63. PubMed ID: 18678350 [TBL] [Abstract][Full Text] [Related]
20. Binding characteristics and biological activity of 17 alpha-[125I]iodovinyl-11 beta-methoxyestradiol, an estrogen receptor-binding radiopharmaceutical, in human breast cancer cells (MCF-7). McManaway ME; Jagoda EM; Eckelman WC; Larson SM; Francis BE; Gibson RE; Reba RC; Lippman ME Cancer Res; 1986 May; 46(5):2386-9. PubMed ID: 3697981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]